A race is reportedly underway for healthcare businesses to get coronavirus take-home testing kits onto the public market with EverlyWell and Nurx leading the pack.
EverlyWell will launch $135 kits Monday, making some 30,000 tests available, promising results within 48 hours, according to mobihealthnews.com.
Positive results will be communicated to mandated federal and state reporting agencies.
Meanwhile, Nurx, best known for its at-home sexually transmitted infection testing, is teaming with Molecular Testing Labs with a plan to launch a telehealth consultation and home-testing service "within the week," the digital news site reported.
Similar to EverlyWell, Nurx and Molecular plan on overnighting the test to patients, who can collect samples and send back their results in prepaid packaging. Nurx will then provide telehealth to patients about their next steps.
Roche has also been working on providing tests for the virus, the health news site reported, announcing Monday it began the first shipment of tests to a network of hospitals and reference labs across the United States. The initial shipments included 400,000 test kits.
© 2021 Newsmax. All rights reserved.